Salvia Biotechnology

byVasil GeorgievEditorAtanas Pavlov

Hardcover | April 9, 2018

Salvia Biotechnology by Vasil Georgiev
$212.95
Earn 1,065 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

The genusSalviarepresents nearly 1,000 species that are widely distributed around the world. It is the largest in theLamiaceaefamily. Traditionally, infusions ofSalviaspecies have been widely used to treat oral inflammation, throat and headaches, and digestive disturbances in various folklore- and ethno-medicine practices worldwide. The antispasmodic, antiseptic and hypoglycemic effects of their extracts have been recognized by the ancient healers a long time ago before the development of modern medicine. With the advances in phytochemistry and pharmacology, terpenes, polyphenols and volatile compounds have been recognized as the source of bioactivity inSalviaextracts. Nowadays, because of their valuable pharmaceutical and nutraceutical properties, manySalviaspecies have been widely used as ingredients in food, pharmacy and cosmetic industries. The economic importance ofSalviaplants continues to increase, following closely the growing interest to the concept for modern healthy lifestyle, based on prevention by consuming quality foods and nutraceutical supplements of natural origin.

However, the growing demand has led to overexploitation of natural habitats and in the last few years many wild growingSalviaspecies have shrunk or fallen under threat. Obviously, to deal with that problem and to prevent ecological crisis, there is an urgent need for alternative, renewable sources ofSalviabiomass. Plant biotechnology can provide a wide range of tools for development of economically feasible continuous production of standardized valuable phytochemicals. Plantin vitroculture technology is a powerful method for continuous production of plant secondary metabolites under controlled conditions, recently adapted to variousSalviaspecies.Salvia in vitrosystems are harmless to natural plant populations and can be grown independently of environmental factors, geographical latitude, climatic change, and seasonal variations. Several bioactive metabolites from rare and endangeredSalviaplants can be produced by employing different plantin vitrosystems. However, the researches on development of large scale biotechnology, based onSalvia in vitrosystems, are still in early stages and many points still have to be addressed before the commercialization to take place.

In this book we intend to summarize the recent achievements in research withSalvia in vitrosystems as biological matrixes for the production of pharmaceutically important secondary metabolites. Further we invited leading experts to present their recent studies on phytochemistry, ethnobotanical and ethnophamacological aspects of genusSalvia. Safety and legal issues related to implementation ofSalviaplants andin vitrocultures extracts in foods, cosmetics and pharmaceutical products will be discussed as well.

Dr. Vasil Georgiev obtained his PhD at The Stephan Angeloff Institute of Microbiology - Bulgarian Academy of Sciences in 2009. He is an expert on bioprocess engineering and secondary metabolites production by plant cells, tissue and organ cultures, functional genomics, metabolite profiling, development and improvement of plant in vitro...
Loading
Title:Salvia BiotechnologyFormat:HardcoverProduct dimensions:427 pages, 9.25 X 6.1 X 0 inShipping dimensions:427 pages, 9.25 X 6.1 X 0 inPublished:April 9, 2018Publisher:Springer NatureLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3319738992

ISBN - 13:9783319738994

Appropriate for ages: All ages

Look for similar items by category: